Use of percutaneous mechanical circulatory support for right ventricular failure.
Kartik GuptaAlejandro LemorAhmad AlkhatibPatrick McBrideJennifer CowgerGillian GraftonKhaldoon AlaswadWilliam O'NeillPedro VillablancaMir Babar BasirPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
In our real-world cohort, 52% of patients treated with RV-MCS survived their index hospitalization. Serum lactate at presentation and CVP were the strongest predictors of in-hospital mortality.